Related Experiment Video
Updated: Mar 18, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
E3 ubiquitin ligase: A potential regulator in fibrosis and systemic sclerosis
Xiao-Lei Huang1, Li Zhang2, Yu Duan1
1Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China.
Abstract:
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis in the skin and internal organs. The pathogenesis of SSc is not completely understood until now. Recently, many studies have focused on the role of E3 ubiquitin ligases in organ fibrosis. However, the possible regulatory mechanisms of E3 ubiquitin ligases in fibrosis and SSc are not well documented. In this review, we summarized that E3 ubiquitin ligases regulated fibrosis through ubiquitin-mediated degradation of TGF-β/Smad signaling pathway. Moreover, E3 ubiquitin ligases participated in regulating fibrosis by other methods, such as inducing epithelial transition to mesenchymal cell, enhancing the production of TGF-β and protecting activated hepatic stellate cells from apoptosis. However, the specific regulatory mechanisms of E3 ubiquitin ligases in scleroderma is still not fully understood. There are more works to be done to specify the mechanism of E3 ubiquitin ligases in regulation of fibrosis in SSc.
Insights
E3 ubiquitin ligases play a role in systemic sclerosis (SSc) fibrosis by degrading key signaling pathways and influencing cell behavior. Further research is needed to fully understand their specific mechanisms in SSc.
Area of Science:
- Biochemistry
- Immunology
- Cell Biology
Background:
- Systemic sclerosis (SSc) is an autoimmune disorder causing organ fibrosis.
- The precise mechanisms driving SSc pathogenesis remain unclear.
- E3 ubiquitin ligases are increasingly recognized for their role in organ fibrosis.
Purpose of the Study:
- To review the regulatory mechanisms of E3 ubiquitin ligases in fibrosis.
- To explore their specific involvement in the pathogenesis of SSc.
Main Methods:
- Literature review of studies on E3 ubiquitin ligases and fibrosis.
- Analysis of documented pathways regulated by E3 ubiquitin ligases.
Main Results:
- E3 ubiquitin ligases regulate fibrosis via ubiquitin-mediated degradation of the TGF-β/Smad signaling pathway.
- They also influence fibrosis by promoting epithelial-to-mesenchymal transition, increasing TGF-β production, and preventing apoptosis of activated hepatic stellate cells.
Conclusions:
- E3 ubiquitin ligases are implicated in fibrosis through multiple mechanisms.
- Their specific roles and regulatory functions in systemic sclerosis require further investigation.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of the Unfolded Protein Response
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Master Transcription Regulators
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

